Ovarian tumours of borderline malignancy: Time for a reappraisal?

Current Diagnostic Pathology

Volumn 3, Issue 3, 1996, Pages 143-151

  Fox, H ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006659906     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(05)80012-2     Document Type: Article

References (105)

1. Fox H. The concept of borderline malignancy in ovarian tumours. Curr Top Pathol 1989; 78: 111-134.
2. Russell P. Ovarian epithelial tumours with atypical proliferation. In: Lwe D, Fox H, eds. Advances in Gynaecological Pathology. Edinburgh: Churchill Livingstone, 1992:299-320.
3. Fox H. Ovarian tumours of borderline malignancy. In: Ratnam S S, Sen D K, Arulkumaran S, eds. Contributions to Obstetrics and Gynaecology Vol. 3. Singapore: Churchill Livingstone, 1994:327-341.
4. Russell, P. Surface epithelial-stromal tumours of the ovary. In: Fox H, ed. Haines and Taylor: Textbook of Obstetrical and Gynaecological Pathology, 4th Edition. New York: Churchill Livingstone, 1995:743-821.
5. Roth L M, Czemobilsky B, Langley F A. Ovarian endometrioid adenofibromatous and cystadenofibromatous tumors: benign, proliferating and malignant. Cancer 1981; 40: 1838-1845.
6. Bell D A, Scully R E. Atypical and borderline endometrioid adenofibromas of the ovary: a report of 27 cases. Am J Surg Patholl985;9:205-214.
7. Snyder R R, Noms H J, Tavassoli F A. Endometrioid proliferative and low malignant potential tumors of the ovary: a clinicopathologic study of 46 cases. Am J Surg Pathol 1988; 12:661-671.
8. Norris H J. Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary. Int J Gynecol Pathol 1993;12: 134-140.
9. Roth L M, Langley F A, Fox H, Wheeler J H, Czemobilsky B. Ovarian clear cell adenofibromatous tumors: benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer 1984; 53: 1653-1664.
10. Bell D A, Scully R E. Benign and borderline clear cell adenofibromas of the ovary. Cancer 1985; 65: 2922-2931.
11. Roth L M, Dallenbach-Hellweg G, Czemobilsky B. Ovarian Brenner tumors: 1. Metaplastic, proliferating, and of low malignant potential. Cancer 1985; 56:582-591.
12. Roth L M, Gersell D J, Ulbright T M. Ovarian Brennner tumors and transitional cell carcinoma: recent developments. Int J Gynecol Pathol 1993; 12: 128-133.
13. Serov S F, Scully R E, Sobin L H. International Histological Classification of Tumours. No 9. Histological Typing of Ovarian Tumours. Geneva: World Health Organization, 1973.
14. Ovarian Tumour Panel of the Royal College of Obstetricians and Gynaecologists. Ovarian epithelial tumours of borderline malignancy: pathological features and current status. Br J Obstet Gynaecol 1983; 90: 743-750.
15. Bell D A, Rutgers J L, Scully R E. Ovarian epithelial tumors of borderline malignancy. In: Damjanov I, Cohen A, Mills S E, Young R H, eds. Progress in Reproductive and Urinary Tract Pathology, Vol. 1. Philadelphia: Field and Wood, 1989; 1-30.
16. Hart W R, Norris H J. Borderline and malignant mucinous tumors of the ovary. Cancer 1973; 31: 1031-1045.
17. Hart W R. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol 1977; 8:541-549.
18. Hart W R. Pathology of malignant and borderline (low malignant potential) epithelial tumors of the ovary. In: Coppleson M, Monaghan J, Morrow C P, Tattersall M R N, eds. Gynecologic Oncology, 2nd Edition. Edinburgh: Churchill Livingstone, 1992; 863-887.
19. Chaitin B A, Gershenson D M, Evans H L. Mucinous tumors of the ovary: a clinicopathologic study of 70 cases. Cancer 1985; 55: 1958-1962.
20. Sumithran E, Susil B J, Looi L. The prognostic significance of grading in borderline mucinous tumors of the ovary. Hum Pathol 1988; 19: 15-18.
21. Watkin W, Suva E G, Gershenson D M. Mucinous carcinoma of the ovary: pathologic prognostic factors. Cancer 1992; 69: 208-212.
22. Russell P. The pathological assessment of ovarian neoplasms. II. The proliferating epithelial tumours. Pathology 1979; 11:251-282.
23. Siriaunkgul S, Robbins K M, McGowan L, Silverberg S G. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and Mullerian type. Int J Gynecol Pathol 1995; 14: 198-208.
24. Yoonessi K, Crickard K, Celic C, Yoonessi S. Borderline epithelial tumors of the ovary: ovarian intraepithelial neoplasia. Obstet Gynecol Surv 1988; 43:435-144.
25. Plaxe S C, Deligdisch L, Dottino P R, Cohen C J. Ovarian intraepithelial neoplasia demonstrated in patients with Stage I ovarian carcinoma. Gynecol Oncol 1990; 38: 367-372.
26. Tavassoli F A. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion). Mod Pathol 1988; 1:407-414.
27. Bell D A, Scully R E. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990; 21:397-403.
28. Russell P, Ballantyne P. Surgical Pathology of the Ovaries. Edinburgh: Churchill Livingstone, 1989.
29. Purola E. Serous papillary ovarian tumours: a study of 233 cases with special reference to the histological type of tumour and its influence on prognosis. Acta Obstet Gynaecol Scand 1963; 42 (SuppI 3): 1-77.
30. Julian C G, Woodruff J D. The biologic behaviour of low grade papillary serous carcinoma of the ovary. Obstet Gynecol 1972; 40: 360-368.
31. Katzenstein A A, Mazur M T, Morgan T E, Kao G F. Proliferate serous tumors of the ovary: histologie features and prognosis. Am J Surg Pathol 1978; 2: 339-355.
32. Tang M, Lian L, Liu T. The characteristics of ovarian serous tumors of borderline malignancy. Chinese Med J 1980; 92: 459-464.
33. Tasker M, Langley F A. The outlook for women with borderline epithelial tumours of the ovary. Br J Obstet Gynaecol 1985; 92: 969-973.
34. Tazelaar H D, Bostwick D G, Ballon S C, Hendrickson M R, Kempson R L. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985; 66:417-422.
35. Kliman L, Rome R M, Fortune D W. Low malignant potential tumors of the ovary: a study of 76 cases. Obstet Gynecol 1986; 68: 338-344.
36. Nakashima N, Nagasaka T, Oiwa N et al. Ovarian epithelial tumors of borderline malignancy in Japan. Gynecol Oncol 1990; 38: 90-98.
37. Massad L S, Hunter V J, Szpakca C A, Clarke-Pearson D L, Creasman W T. Epithelial ovarian tumors of low malignant potential. Obstet Gynecol 1991; 78: 1027-1032.
38. Kaem J, Trope C G, Abeler V M. A retrospective study of 370 ovarian borderline tumors treated at the Norwegian Radium Hospital from 1970 to 1982: a clinical and histopathological review. Cancer 1993; 71: 1810-1820.
39. Sykes P, Quinn M, Rome R. Ovarian tumors of low malignant potential: a retrospective study of 234 patients. Int J Gynecol Cancer 1996; 6: (in press).
40. Burks R T, Sherman M E, Kurman R J. Micropapillary serous carcinoma of the ovary and peritoneum: a distinctive low grade carcinoma related to serous borderline tumors, (submitted for publication).
41. Seidman J D, Kurman R J. Subclassification of serous borderline tumors of the ovary into benign and malignant types: a clinicopathologic study of 65 advanced stage cases, (submitted for publication).
42. Aure J C, Hoeg K, Kolstad P. Clinical and histologie studies of ovarian carcinoma: long term follow-up of 990 cases. Obstet Gynecol 1971; 37: 1-9.
43. Nikrui N. Survey of clinical behaviour of patients with borderline epithelial tumours of the ovary. Gynecol Oncol 1981; 12:107-119.
44. Russell P. Borderline epithelial tumours of the ovary: a conceptual dilemma. Clinics Obstet Gynaecol 1984; 11: 259-277.
45. Gershenson D M, Suva E G. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 1990; 65: 578-585.
46. Trimble C L, Trimble E L. Management of epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1994; 55: 552-561.
47. McCaughey W T E, Kirk M E, Lester W, Dardick 1. Peritoneal epithelial lesions associated with proliferative serous tumours of the ovary. Histopathology 1984; 8: 195-208.
48. Michael H, Roth L M. Invasive and non-invasive implants in ovarian serous tumors of low malignant potential. Cancer 1986; 57: 1240-1247.
49. Bell D A, Weinstock M A, Scully R E. Peritoneal implants of ovarian serous borderline tumors: histologie features and prognosis. Cancer 1988; 62: 2212-2222.
50. Lauchlan S C. The secondary Mullerian system. Obstet Gynecol Surv 1972; 27: 133-146.
51. Lauchlan S C. The secondary Mullerian system revisited. Int J Gynecol Pathol 1994;13: 73-79.
52. Segal G H, Hart W R. Ovarian serous tumors of low malignant potential (serous borderline tumors): the relationship of exophytic surface tumor to peritoneal 'implants'. Am J Surg Pathol 1992; 16: 577-583.
53. Tutschka B G, Lauchlan S C. Endosalpingiosis. Obstet Gynecol 1980; 55: 57s-60s.
54. Zinser K R, Wheeler J E. Endosalpingiosis in the omentum: a study of autopsy and surgical material. Am J Surg Pathol 1982; 6:109-117.
55. Bell D A. Pathology of the peritoneum and secondary Mullerian system. In: Fox H, ed. Haines and Taylor: Obstetrical and Gynaecological Pathology, 4th. Edition. New York: Churchill Livingstone, 1995; 997-1014.
56. Dallenbach-Hellvveg G. Atypical endosalpingiosis: a case report with consideration of the differential diagnosis of glandular subperitoneal inclusions. Path Res Pract 1987; 182: 180-182.
57. Bell D A, Scully R E. Serous borderline tumors of the peritoneum. Am J Surg Pathol 1990; 14:230-239.
58. Biscotti C V, Hart Wr. Peritoneal serous micropapillomatosis of low malignant potential (serous borderline tumors of the peritoneum): a clinicopathologic study of 17 cases. Am J Surg Pathol 1992; 16:467-475.
59. Farnsworth H, Russell P. Extraovarian tumours of Mullerian type. In: Lowe D, Fox H. eds. Advances in Gynaecological Pathology. Edinburgh: Churchill Livingstone, 1992; 321-341.
60. Creasman W T, Parks R, Noms H, DiSia P J, Morrow C P, Hreschchyshyn M M. Stage I borderline ovarian tumors. Obstet Gynecol 1982; 59: 93-96.
61. Colgan T J, Noms H J. Ovarian epithelial tumors of low malignant potential: a review. Int J Gynecol Pathol 1983; 1:367-382.
62. Yaazigi R, Sandstad J, Munoz A K. Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 1988; 31:402-(08.
63. Leake J F, Rader J S, Woodruff J D, Rosenhein N B. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991; 42: 124-130.
64. Di Re F, Paladini D, Fontanelli R, Feudale E A A, Raspagliesi F. Surgical staging for epithelial ovarian tumors of low malignant potential. Int J Gynecol Cancer 1994; 4: 310-314.
65. Lim-Tan S K, Cagigas H A, Scully R E. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol 1988; 72: 775-781.
66. Dgani R, Blickstein I, Stroham Z et al. Clinical aspects of ovarian tumors of low malignant potential. Eur J Obstet Gynecol Reprod Biol 1990 35:251-258.
67. Rice L W, Berkowitz R S, Mark S D, Yavner D L, Lage J M. Ovarian epithelial tumors of borderline malignancy. Gynecol Oncol 1990; 39: 195-198.
68. Ayhan A, Atakin R, Develioglu O, Yarali H, Kucukali T, Bilgin F. Borderline epithelial tumours. Aust NZ J Obstet Gynaecol 1991; 31: 174-176.
69. Sawada M, Yamasaki M, Urabe T, Hashimoto K, Katayama S. Stage I epithelial ovarian tumors of low malignant potential. Jap J Clin Oncol 1991; 21: 30-34.
70. Manchul L A, Simm J, Levin W et al. Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment. Int J Rad Oncol Biol Phys 1992; 22: 867-874.
71. de Nictolis M, Montironi R, Tommasoni S et al Serous borderline tumors of the ovary: a clinicopathologic, immunohistochemical, and quantitative study of 44 cases. Cancer 1992; 70: 152-160.
72. Piura B, Dgani R, Blickstein I, Yanai-Inbar I, Czernobilsky B. Epithelial ovarian tumors of borderline malignancy: a study of 50 cases. Int J Gynecol Cancer 1992;2: 189-197.
73. Kurman R J, Trimble C L. The behaviour of serous tumours of low malignant potential: are they ever malignant? Int J Gynecol Pathol 1993; 12: 12-127.
74. Padberg B-C, Stegner H-E, von Sengbusch S, Arps H, Schroder S. DNA cytophometry and immunocytochemistry in ovarian tumours of borderline malignancy and related peritoneal lesions. Virchows Archiv A Pathol Anat 1992; 421:497-503.
75. Rutgers J L, Scully R E. Ovarian Mullerian mucinous papillary cystadenomas of borderline malignancy: a clinicopathologic analysis. Cancer 1988; 61: 340-348.
76. de Nictolis M, Montironi R, Tommasoni S et al. Benign, borderline, and well differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, immunohistochemical, and nuclear quantitative study of 57 cases. In J Gynecol Pathol 1994; 13: 10-21 .
77. Guerriere C, Hogberg T, Wingren S, Fristedt S, Simonsen E, Boeryd B. Mucinous borderline and malignant tumors of the ovary. Cancer 1994; 74: 2329-2334.
78. Russell P, Merkur H. Proliferating ovarian 'epithelial' tumours: a clinicopathologic analysis of 144 cases. Aust NZ J Obstet Gynaecol 1989; 19:45-51.
79. Barnhill D, Heller P, Brzozowski P, Advani H, Gallup D, Park R. Epithelial ovarian carcinoma of low malignant potential. Obstet Gynecol 1985; 65: 53-58.
80. Bostwick D G, Tazelaar H D, Ballon S C, Hendrickson M R, Kempson R L. Ovarian epithelial tumors of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer 1986; 58: 2052-2065.
81. Nation J G, Krepart G V. Ovarian carcinoma of low malignant potential: staging and treatment. Am J Obstet Gynecol 1986; 154: 290-293.
82. Young R H, Gilks S B, Scully R E. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei: a clinicopathological analysis of 22 cases. Am J Surg Pathol 1991; 15:415-429.
83. Ronnett B M, Kurman R J, Zahn C M et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995; 26:509-524.
84. Ronnett B M, Zahn C M, Kurman R J et al. Disseminated peritoneal adenomucinosis and peritoneal carcinomatosis. Am J Surg Pathol 1995; 19: 1390-1408.
85. Prayson, R A, Hart W R, Petras R E. Pseudomyxoma peritonei: a clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994; 18: 591-603.
86. Seidman J D, Elsayed A M, Sobin L H, Tavassoli F A. Association of mucinous tumors of the ovary and appendix: a clinicopathologic study of 25 cases. Am J Surg Pathol 1993; 17: 22-34.
87. Cuatrecasas M, Matias-Guiu X, Prat J. K-ras mutation pattern supports a clonal nature of synchronous ovarian and appendiceal mucinous tumo'rs (abstract. United States and Canadian Academy of Pathology Annual Meeting. Toronto, 1995; 88.
88. Chuaqui R, Zhuang Z, Emmert-Buck M R et al. Genetic analysis of synchronous tumors of ovary and appendix to determine site of origin (abstract). United States and Canadian Academy of Pathology Annual Meeting. Toronto, 1995; 87.
89. Seidman J D, Kurman R W. Classification of ovarian serous borderline tumors (BST) into benign and malignant types: a clinicopathologic study of 65 advanced stage cases (abstract). United States and Canadian Academy of Pathology Annual Meeting. Washington, 1996; 97.
90. Suva E, Tomos C, Zhuang Z, Merino M, Gershenson D. Tumor recurrence in Stage I ovarian serous low malignant potential neoplasms (abstract). United States and Canadian Academy of Pathology Annual Meeting. Washington, 1996; 98.
91. Baak J, Fox H, Langley F A, Buckley C H. The prognostic value of morphometry in ovarian epithelial tumors of borderline malignancy. Int J Gynecol Pathol 1985; 4: 186-191.
92. Friedlander M L, Russell P, Taylor I W, Hedley D W, Tattersall M H N. Flow cytometric analysis of cellular DNA contentas an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology 1984; 16: 301-306.
93. Dietel M, Arps H, Rohlff A, Bodecker R, Niendorf A. Nuclear DNA content of borderline tumors of the ovary: correlation with histology and significance for prognosis. Virchows Archiv A Path Anat 1986; 409: 829-836.
94. Fu Y S, Ro J, Reagan J W, Hall T L, Berek J. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors. Obstet Gynecol 1986; 67:478-t82.
95. Olincini C D, Caluser I. DNA nuclear content in borderline ovarian tumors. Morphol Embryol 1988; 24:49-52.
96. Griffiths A P, Cross D, Kingston RE, Harkin P, Wells M, Quirke P. Flow cytometry and AGNORs in benign, borderline, and malignant mucinous and serous tumors of the ovary. Int J Gynecol Pathol 1993; 12: 307-314.
97. Seidman, J D, Noms H J, Griffin J L, Hitchcock C L. DNA flow cytometric analysis of serous ovarian tumors of low malignant potential. Cancer 1993; 71: 3947-3951.
98. Kaern J, Trope C G, Kristensen G B, Abeler V M, Pettersen E O. DNA ploidy: the most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 1993; 3: 349-358.
99. Kacinski B, Mayer A, King B, Cabnter D, Chambers S. Neu protein overexpression in benign, borderline, and malignant ovarian neoplasms. Gynecol Oncol 1992; 44: 245-253.
100. Teneriello M G, Ebina M, Linnoila R 1 et al. p53 and Ki-ras mutations in epithelial ovarian neoplasms. Cancer Res 1993; 85: 1513-1519.
101. Klemi P J, Takahashi S, Joensuu H, Kiiholma P, Narimatsu E, Mori M. Immunohistochemical detection of p53 protein in borderline and malignant serous ovarian tumors. Int J Gynecol Pathol 1994;13: 228-233.
102. Wertheim l, Muto M G, Welch W R, Bell D A, Berkowitz R S, Mok S C. p53 gene mutation in human borderline epithelial ovarian tumors. J NatI Cancer Inst 1994; 86: 1549-1551.
103. Kupryjanczyk J, Bell D A, Yandell D W, Scully R E, Thor A D. p53 expression in ovarian borderline tumors and stage I carcinomas. Am J Clin Pathol; 1994; 102: 671-676.
104. Kupryjanczyk J, Bell D A, Dimeo D, Beauchamp R, Thor A D, Yandell D W. p53 gene analysis of ovarian borderline tumors and stage I carcinomas. Hum Pathol 1995; 26: 387-392.
105. Cheng P C, Gosewehr J A, Kim T M et al. Potential role of the inactivated X chromosome in ovarian epithelial tumour development. J Natl Cancer Inst 1996; 88: 510-518.